R01 CA134675-04/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA).

Banerjee SR, Pullambhatla M, Shallal H, Lisok A, Mease RC, Pomper MG. Banerjee SR, et al. Oncotarget. 2011 Dec;2(12):1244-53. doi: 10.18632/oncotarget.415. Oncotarget. 2011. PMID: 22207391 Free PMC article.

2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.

Chen Y, Pullambhatla M, Foss CA, Byun Y, Nimmagadda S, Senthamizhchelvan S, Sgouros G, Mease RC, Pomper MG. Chen Y, et al. Clin Cancer Res. 2011 Dec 15;17(24):7645-53. doi: 10.1158/1078-0432.CCR-11-1357. Epub 2011 Oct 31. Clin Cancer Res. 2011. PMID: 22042970 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters